Company Five Prime Therapeutics, Inc.
Equities
FPRX
US33830X1046
Biotechnology & Medical Research
Business Summary
Number of employees: 51
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Reese
CEO | Chief Executive Officer | 61 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 47,341,318 | 45,500,078 ( 96.11 %) | 769,289 ( 1.625 %) | 96.11 % |
Company contact information
Five Prime Therapeutics, Inc.
111 Oyster Point Boulevard
94080-7047, South San Francisco
+415 365 5600
http://www.fiveprime.comSector
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |